Overview

Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum

Status:
Withdrawn
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of Humira in the treatment of pyoderma gangrenosum.
Phase:
Phase 2
Details
Lead Sponsor:
Wright State University
Collaborators:
Stanford University
Wake Forest University
Treatments:
Adalimumab